Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome

NCT: NCT06620198 · ACTIVE_NOT_RECRUITING

NCT IDNCT06620198
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-01
Completion2027-10-01
SponsorI.R.C.C.S. Fondazione Santa Lucia (OTHER)
First posted
Last updated

Brief Summary

Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually. The aim of this double-blind randomized controlled trial with a SHAM control group is to evaluate the effects of robot-assisted therapy, integrated with conventional therapy, on upper limb motor recovery in patients with GBS.

Frequently Asked Questions

What is Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome?

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome is a clinical trial registered under NCT06620198. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06620198?

The current status of NCT06620198 (Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome) is: ACTIVE_NOT_RECRUITING.

When did Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome start?

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome started on 2024-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑